P1.242. One-Year Overall and Disease-Free Survival After Uniportal Robotic-Assisted Minimally Invasive Esophagectomy

Clicks: 3
ID: 325732
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #138 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – technique Background Uniportal robotic-assisted minimally invasive esophagectomy has demonstrated perioperative safety in preliminary experience; however, its oncologic outcomes remain to be established. This study aimed to evaluate one-year overall survival and disease-free survival after uniportal robotic-assisted minimally invasive esophagectomy. Methods Patients who underwent uniportal robotic-assisted minimally invasive esophagectomy between September 2024 and July 2025 were retrospectively reviewed. The primary outcome was one-year overall survival and disease-free survival. Oncologic adequacy, including the complete resection rate with microscopically negative margins and lymph node yield, was also assessed. Perioperative outcomes were analyzed descriptively. Results Twenty-one patients underwent uniportal robotic-assisted minimally invasive esophagectomy. Squamous cell carcinoma accounted for 81%, and 62% had stage III–IV disease; 71% received neoadjuvant therapy. Complete resection with microscopically negative margins was achieved in 95%, with a median lymph node yield of 34. At a median follow-up of 11.1 months, the overall survival and disease-free survival for the entire cohort were 83% and 76%, respectively. In stage I–II disease, both overall survival and disease-free survival were 100%. In stage III–IV disease, overall survival and disease-free survival were 74% and 62%, respectively. Conclusion Uniportal robotic-assisted minimally invasive esophagectomy is feasible and demonstrates encouraging early oncologic outcomes, even in a cohort with predominantly advanced-stage disease.
Reference Key
openalex_W7203885225 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ting-Fang Kuo, Jang‐Ming Lee
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.390
URL
https://doi.org/10.1093/dote/doag077.390
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.